Breakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs).
The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies.
Health and wellness will be the primary focus of the "Entre Nosotras" Health Fair, which will take place on July 13 from 10 a.m. to 12 p.m. at Ana G. Méndez University's South Florida Campus. A long list of experts will be participating in the health fair, providing different services and counseling to the community.Read More
Jeff Ber at Oneball, Alberta Health Services, and the University of Calgary are working on a study to understand the impact of testicular cancer better.Read More
Researchers will use IASLC/LCFA funds to create new lung cancer treatments for never-smokers and patients whose cancer has spreadRead More
CogniFit research team has developed a digital neuropsychological test designed to help screen cognitive difficulties in cancer patients who are experiencing the mental fog known as chemo brainRead More
Planet TV Studios produces cutting-edge, real-life, television series that feature insightful, meaningful updates on the most important business, medical and social responsible topics currently taking place in the areas most important to our lives.Read More
Flow cytometry provides a highly adaptable and quantitative method for investigating both the cellular distribution and intracellular changes that occur in tumors and peripheral lymphoid organs in response to therapy.Read More